Severe COVID-19 in adults is characterized by a hyperinflammatory response that typically occurs in the second week of illness with abnormal biomarkers such as lymphopenia and raised C-reactive protein (CRP) levels (21, 22). The gene discussed is CRP; the disease is COVID-19.